| Q64326114 | "They Should Be Asking Us": A Qualitative Decisional Needs Assessment for Women Considering Cervical Cancer Screening |
| Q36731053 | A Randomized Trial of Human Papillomavirus Self-Sampling as an Intervention to Promote Cervical Cancer Screening Among Women With HIV. |
| Q40191221 | A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial |
| Q54970397 | A comparison of cotton and flocked swabs for vaginal self-sample collection. |
| Q35906317 | A door-to-door approach to cervical cancer screening |
| Q64076777 | A novel sequencing-based vaginal health assay combining self-sampling, HPV detection and genotyping, STI detection, and vaginal microbiome analysis |
| Q38739053 | A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador |
| Q42202170 | A prospective double-blind cross-sectional study of the accuracy of the use of dry vaginal tampons for self-sampling of human papillomaviruses |
| Q41658208 | A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening |
| Q89563783 | A randomized trial of mailed HPV self-sampling for cervical cancer screening among ethnic minority women in South Florida |
| Q37632090 | A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa |
| Q40902825 | Acceptability and Feasibility of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening |
| Q64077490 | Acceptability of Human Papillomavirus Self-Sampling Among a National Sample of Women in the United States |
| Q40284466 | Acceptability of self-sample human papillomavirus testing among medically underserved women visiting the emergency department |
| Q40238949 | Accuracy of self-collected human papillomavirus samples from Japanese women with abnormal cervical cytology |
| Q40117003 | Accuracy of self-collected vaginal dry swabs using the Xpert human papillomavirus assay. |
| Q90232274 | Advances in Precision Health and Emerging Diagnostics for Women |
| Q91996765 | Age-related acceptability of vaginal self-sampling in cervical cancer screening at two university hospitals: a pilot cross-sectional study |
| Q41066018 | Age-specific performance of careHPV versus Papanicolaou and visual inspection of cervix with acetic acid testing in a primary cervical cancer screening |
| Q47122302 | Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing? |
| Q51847800 | Arguments in favor of HPV testing for cervical screening and post-treatment CIN2+ monitoring. |
| Q40727294 | Assessing Acceptability of Self-Sampling Kits, Prevalence, and Risk Factors for Human Papillomavirus Infection in American Indian Women |
| Q41637628 | Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program |
| Q92572720 | Assessment of clinical performance of an ultrasensitive nanowire assay for detecting human papillomavirus DNA in urine |
| Q33825915 | Assessment of high-risk human papillomavirus infections using clinician- and self-collected cervical sampling methods in rural women from far western Nepal |
| Q36118724 | At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction |
| Q37381520 | BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer |
| Q41057743 | Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing |
| Q45894310 | Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study |
| Q35641828 | Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years |
| Q47397671 | Candidate biomarkers in the cervical vaginal fluid for the (self-)diagnosis of cervical precancer. |
| Q35985481 | Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011. |
| Q36258530 | Cervical Cancer Screening for Patients on the Female-to-Male Spectrum: a Narrative Review and Guide for Clinicians |
| Q33891238 | Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach |
| Q37011809 | Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage |
| Q60046629 | Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing |
| Q96166479 | Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC) |
| Q41444452 | Cervicovaginal HPV infection in female renal transplant recipients: an observational, self-sampling based, cohort study |
| Q50091402 | Challenges in educating women about human papillomavirus (HPV) and HPV screening test results: Experience from an HPV demonstration project in North-Eastern Thailand |
| Q93075461 | Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana |
| Q57826844 | Clearance and persistence of the human papillomavirus infection among Cameroonian women |
| Q36066822 | Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework |
| Q38213987 | Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. |
| Q100413531 | Clinical needs for transgender men in the gynecologic oncology setting |
| Q36861256 | Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study). |
| Q38884083 | Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening |
| Q41330441 | Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment |
| Q64970594 | Community-based self-collected human papillomavirus screening in rural Zimbabwe. |
| Q38655092 | Comparative analysis of vaginal microbiota sampling using 16S rRNA gene analysis |
| Q41006023 | Comparative evaluation of two vaginal self-sampling devices for the detection of human papillomavirus infections |
| Q42212838 | Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening. |
| Q37560148 | Comparison of Human Papillomavirus Detection in Urine and Cervical Samples Using High-Risk HPV DNA Testing in Northern Thailand |
| Q91797606 | Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of |
| Q55234176 | Completing the cervical screening pathway: Factors that facilitate the increase of self-collection uptake among under-screened and never-screened women, an Australian pilot study. |
| Q35784964 | Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination |
| Q91339031 | Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland |
| Q38850707 | Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting |
| Q48451892 | Could urine testing be the future of cervical cancer screening? |
| Q35678378 | DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women |
| Q60307067 | Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses |
| Q35235853 | Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons |
| Q38420013 | Detection of high-risk human papillomavirus using menstrual blood in women with high-grade squamous intraepithelial lesions or high-risk human papillomavirus infections: A pilot study |
| Q89596833 | Developing SMS Content to Promote Papanicolaou Triage Among Women Who Performed HPV Self-collection Test: Qualitative Study |
| Q38967050 | Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma. |
| Q40485993 | Does lack of resources impair access to breast and cervical cancer screening in Japan? |
| Q57068196 | Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China |
| Q41524360 | Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial |
| Q38772035 | Effects of an Education Intervention about HPV Self-Testing for Healthcare Providers and Staff |
| Q37545339 | Efficacy of self-sampling in promoting participation to cervical cancer screening also in subsequent round. |
| Q90367685 | Efficacy of strategies to increase participation in cervical cancer screening: GPs offering self-sampling kits for HPV testing versus recommendations to have a pap smear taken - A randomised controlled trial |
| Q36102272 | Eliciting women's cervical screening preferences: a mixed methods systematic review protocol |
| Q30239987 | Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice |
| Q37640740 | Evaluation of scaling-up of HPV self-collection offered by community health workers at home visits to increase screening among socially vulnerable under-screened women in Jujuy Province, Argentina |
| Q47097439 | Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel |
| Q61446811 | Evaluation of the self-sampling for cervical cancer screening in Bolivia |
| Q41509630 | Examining Acceptability of Self-Collection for Human Papillomavirus Testing Among Women and Healthcare Providers with a Broader Lens |
| Q40406285 | Excellent analytical and clinical performance of a dry self-sampling device for human papillomavirus detection in an urban Chinese referral population |
| Q91759512 | Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands |
| Q40651861 | FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women |
| Q37040460 | Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens |
| Q34344776 | Filling a gap in cervical cancer screening programmes |
| Q90149642 | From potential to practice: how accelerating access to HPV tests and screen and treat programmes can help eliminate cervical cancer |
| Q92318375 | Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia |
| Q37697062 | Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma |
| Q64889875 | Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer. |
| Q104500171 | Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial |
| Q88210623 | HPV Self-Sampling for Cervical Cancer Screening Among Ethnic Minority Women in South Florida: a Randomized Trial |
| Q31121182 | HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data |
| Q96134111 | HPV sampling options for cervical cancer screening: preferences of urban-dwelling Canadians in a changing paradigm |
| Q50891269 | HPV self-sampling in Japanese women: A feasibility study in a population with limited experience of tampon use. |
| Q42242864 | HPV self-testing and cervical cancer screening coverage. |
| Q36341195 | HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population |
| Q92979071 | HPV testing on vaginal/cervical nurse-assisted self-samples versus clinician-taken specimens and the HPV prevalence, in Adama Town, Ethiopia |
| Q26779531 | HPV testing: a mixed-method approach to understand why women prefer self-collection in a middle-income country |
| Q46902171 | HPV-FASTER: broadening the scope for prevention of HPV-related cancer |
| Q92087486 | HPV-based cervical cancer screening, including self-sampling, versus screening with cytology in Argentina |
| Q38372386 | HPV-based cervical cancer screening- facts, fiction, and misperceptions |
| Q90805909 | HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme |
| Q40168986 | Health agents' perspective on the incorporation of self-collected samples in HPV screening programs |
| Q36716793 | High Rate of β-Globin DNA Detection Validates Self-Sampling in Herpes Simplex Virus Shedding Studies |
| Q38316273 | High-risk HPV testing in the management of atypical glandular cells: A systematic review and meta-analysis. |
| Q50853405 | High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study. |
| Q90302379 | High-risk human papillomavirus messenger RNA testing in wet- and dry- self-collected specimens for high-grade cervical lesion detection in Mombasa, Kenya |
| Q58611750 | Home Self-Collection by Mail to Test for Human Papillomavirus and Sexually Transmitted Infections |
| Q40802588 | Home-based HPV self-sampling improves participation by never-screened and under-screened women: Results from a large randomized trial (iPap) in Australia |
| Q59355860 | Human Papillomavirus Genotypes Predict Progression of Anal Low-Grade Squamous Intraepithelial Lesions |
| Q26799791 | Human papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective |
| Q50126240 | Human papillomavirus genotype and viral load agreement between paired first-void urine and clinician-collected cervical samples |
| Q37839810 | Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study |
| Q40333905 | Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms |
| Q88310623 | Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples |
| Q91843952 | Identification of Circulating MicroRNAs as a Promising Diagnostic Biomarker for Cervical Intraepithelial Neoplasia and Early Cancer: A Meta-Analysis |
| Q91841838 | Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study |
| Q37454312 | Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention |
| Q90398386 | Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study |
| Q55077396 | Implementation considerations using HPV self-collection to reach women under-screened for cervical cancer in high-income settings. |
| Q93031720 | Implementation of Australia's renewed cervical screening program: Preparedness of general practitioners and nurses |
| Q31122156 | Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation |
| Q42680014 | Improving cervical cancer screening attendance in Finland |
| Q54532658 | Improving cervical cancer screening in Baltic, central, and eastern European countries. |
| Q94460622 | Increasing uptake of evidence-based screening services though a community health worker-delivered multimodality program: study protocol for a randomized pragmatic trial |
| Q52651545 | Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S. |
| Q35830446 | Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening |
| Q40299388 | Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm |
| Q55303411 | Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia? |
| Q90201778 | Knowledge and perspectives of the new National Cervical Screening Program: a qualitative interview study of North Queensland women-'I could be that one percent' |
| Q36939313 | Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing |
| Q37586595 | Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial |
| Q40064899 | Mailed Human Papillomavirus Self-Collection With Papanicolaou Test Referral for Infrequently Screened Women in the United States |
| Q26992183 | Major clinical research advances in gynecologic cancer in 2014 |
| Q38837737 | Management of high-risk HPV-positive women for detection of cervical (pre)cancer. |
| Q36298250 | Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature |
| Q42200739 | Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer. |
| Q64103496 | Mixed-methods approach to evaluate an mHealth intervention to increase adherence to triage of human papillomavirus-positive women who have performed self-collection (the ATICA study): study protocol for a hybrid type I cluster randomized effectivenes |
| Q39170424 | Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention |
| Q54587614 | Offering self-sampling to cervical screening non-attenders in primary care. |
| Q30409312 | Optimal positive cutoff points for careHPV testing of clinician- and self-collected specimens in primary cervical cancer screening: an analysis from rural China |
| Q38660469 | Optimizing secondary prevention of cervical cancer: Recent advances and future challenges |
| Q47407043 | Overcoming barriers in HPV vaccination and screening programs. |
| Q64070371 | Pap tests for cervical cancer screening test and contraception: analysis of data from the CONSTANCES cohort study |
| Q39566432 | Patient compliance with cervical smear surveillance in a shared-care setting. |
| Q90161476 | Patient factors affecting successful linkage to treatment in a cervical cancer prevention program in Kenya: A prospective cohort study |
| Q55261992 | Performance of OncoE6 cervical test with collection methods enabling self-sampling. |
| Q91116235 | Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial |
| Q34736619 | Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing |
| Q40116201 | Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders. |
| Q64889933 | Prevalence of Vaccine Type Infections in Vaccinated and Non-Vaccinated Young Women: HPV-IMPACT, a Self-Sampling Study. |
| Q55409918 | Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial. |
| Q64107426 | Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy |
| Q50041872 | Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology |
| Q64892446 | Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches. |
| Q35858955 | Randomized Comparison of Two Vaginal Self-Sampling Methods for Human Papillomavirus Detection: Dry Swab versus FTA Cartridge |
| Q34022208 | Rationale and design of the research project of the South Florida Center for the Reduction of Cancer Health Disparities (SUCCESS): study protocol for a randomized controlled trial |
| Q63914820 | Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women |
| Q37709706 | Recent advances in understanding and preventing human papillomavirus-related disease |
| Q51826646 | Repurposing the vaginal tampon for endometrial cancer detection. |
| Q64135696 | Results of a Pilot Study of a Mail-Based Human Papillomavirus Self-Testing Program for Underscreened Women From Appalachian Ohio |
| Q56909835 | Rethinking the ASCO Resource-Stratified Cervical Cancer Screening Guidelines in the Context of Existing Health Infrastructure in Basic Settings |
| Q38648045 | Screening for cervical cancer in French Guiana: screening rates from 2006 to 2011. |
| Q59806578 | Screening of Cervical Cancer with Self-Collected Cervical Samples and Next-Generation Sequencing |
| Q43924111 | Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline |
| Q55280306 | Self- versus physician-collected samples for the follow-up of human papillomavirus-positive women in sub-Saharan Africa. |
| Q35988357 | Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme |
| Q54229599 | Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs. |
| Q38597267 | Self-administered versus provider-directed sampling in the Anishinaabek Cervical Cancer Screening Study (ACCSS): a qualitative investigation with Canadian First Nations women |
| Q48251892 | Self-collected cervicovaginal sampling for site-of-care primary HPV-based cervical cancer screening: a pilot study in a rural underserved Greek population |
| Q41670583 | Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women |
| Q91116249 | Self-collected versus clinician-collected samples for HPV testing |
| Q55383318 | Self-collection for under-screened women in a National Cervical Screening Program: pilot study. |
| Q36967007 | Self-collection of vaginal swabs for human papillomavirus screening among women in temporary residential programs |
| Q64978939 | Self-sampling coupled to the detection of HPV 16 and 18 E6 protein: A promising option for detection of cervical malignancies in remote areas. |
| Q35958230 | Self-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device. |
| Q38828348 | Self-sampling to improve cervical cancer screening coverage in Switzerland: a randomised controlled trial |
| Q35098354 | Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter |
| Q51807262 | Semi-quantitative HPV viral load in patients with ASC-US cytology: viral load correlates strongly with the presence of CIN, but only weakly with its severity: letter to the editor. |
| Q89763871 | Social innovation in diagnostics: three case studies |
| Q37611863 | Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test |
| Q52673090 | Strategies to reach marginalized women for cervical cancer screening: A qualitative study of stakeholder perspectives. |
| Q36181447 | Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program |
| Q55262796 | The Next Generation of Cervical Cancer Screening: Should Guidelines Focus on Best Practices for the Future or Current Screening Capacity? |
| Q47129496 | The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low- and Middle-Income Countries: A Review and Commentary |
| Q30238947 | The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis |
| Q97568760 | The application of deep learning based diagnostic system to cervical squamous intraepithelial lesions recognition in colposcopy images |
| Q41499207 | The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador |
| Q91440846 | The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador |
| Q35834302 | The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland |
| Q92256596 | The potential of RNA as a target for national screening of pre-cancer |
| Q35887553 | The use of urine in the follow-up of HPV vaccine trials. |
| Q52566780 | Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening. |
| Q36265245 | To what extent will women accept HPV self-sampling for cervical cancer screening? A qualitative study conducted in Switzerland |
| Q57296920 | Too many women are dying from cervix cancer: Problems and solutions |
| Q36803663 | Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer |
| Q36679896 | Triage of HPV positive women in cervical cancer screening |
| Q38824019 | Triage of high-risk HPV positive women in cervical cancer screening. |
| Q36694622 | Use of swabs for dry collection of self-samples to detect human papillomavirus among Malagasy women |
| Q38672124 | Vaginal self-sampling as a diagnosis tool in low-income countries and potential applications for exploring the infectious causes of miscarriage |
| Q28650225 | Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial |
| Q52573825 | Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study. |
| Q36852263 | Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women |
| Q36094822 | Women's Attitudes Toward Cervicovaginal Self-Sampling for High-Risk HPV Infection on the US-Mexico Border |
| Q96016363 | Women's attitudes and understanding of cervical cancer and the new National Cervical Screening Program |
| Q27311434 | Women's experience with home-based self-sampling for human papillomavirus testing |
| Q62486680 | hrHPV Prevalence and Type Distribution in Rural Zimbabwe: A Community-Based Self-Collection Study using Near-Point-of-Care GeneXpert HPV testing |